Melissa McCracken(@MNMcCraken), joined Nextech Invest Ltd.(@nextechinvest) in 2019. She is a scientist by training with a passion for emerging technologies in cancer therapies.
— Sachs Associates (@SachsAssociates) December 21, 2020
e-Meet Melissa at #Sachs_ELSF
More info @ https://t.co/YXBF2fUYBz pic.twitter.com/RGtBFmmykY